title: Antithrombotic selection and risk factor management in ischemic stroke and transient ischemic attack.
abstract: In addition to appropriate antithrombotic therapy, the identification and treatment of modifiable ischemic stroke risk factors can reduce the likelihood of recurrent stroke. Neurosurgeons should be knowledgeable of the specific risk factors and general recommendations for ischemic stroke, as they may play a significant role in the management options for patients with intracranial and extracranial atherosclerotic disease. The authors of this article review the indications for and selection of antithrombotics in patients with cerebral ischemia. In addition, the identification and secondary prevention of select risk factors are discussed.
authors.affiliation: Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota.
authors.forename: Brian S
authors.initials: BS
authors.lastname: Katz
authors.forename: Kelly D
authors.initials: KD
authors.lastname: Flemming
mesh_terms: D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D019090:Case Management; D019587:Dietary Supplements; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D008019:Life Style; D019635:Neurosurgical Procedures; D012307:Risk Factors; D020521:Stroke / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control / Q000601:surgery; D014815:Vitamins / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D014815:Vitamins